|
Originally published In Press as doi:10.1074/jbc.M002547200 on June 28, 2000
J. Biol. Chem., Vol. 275, Issue 43, 33607-33613, October 27, 2000
Direct Functional Interactions between Insulin-like Growth
Factor-binding Protein-3 and Retinoid X Receptor- Regulate
Transcriptional Signaling and Apoptosis*
Bingrong
Liu ,
Ho-Young
Lee§,
Stuart A.
Weinzimer¶,
David
R.
Powell ,
John L.
Clifford§,
Jon M.
Kurie§, and
Pinchas
Cohen **
From the Department of Pediatrics, University of
California, Los Angeles, California 90095-1752, the
§ University of Texas M. D. Anderson Cancer Center,
Houston, Texas 77030, the ¶ Children's Hospital of Philadelphia,
University of Pennsylvania, Philadelphia, Pennsylvania 19104, and the
Department of Pediatrics, Baylor College of Medicine,
Houston, Texas 77030
Insulin-like growth factor-binding protein
(IGFBP)-3 regulates apoptosis in an IGF-independent fashion and has
been shown to localize to nuclei. We cloned the nuclear receptor
retinoid X receptor- (RXR- ) as an IGFBP-3 protein partner in a
yeast two-hybrid screen. Multiple methodologies showed that IGFBP-3 and
RXR- bind each other within the nucleus. IGFBP-3-induced apoptosis
was abolished in RXR- -knockout cells. IGFBP-3 and RXR ligands were
additive in inducing apoptosis in prostate cancer cells. IGFBP-3
enhanced RXR response element and inhibited RARE signaling. Thus,
RXR- -IGFBP-3 interaction leads to modulation of the transcriptional
activity of RXR- and is essential for mediating the effects of
IGFBP-3 on apoptosis.
*
This work was supported in part by Grants 2R01 DK47591 and
1RO1 AI40203 from the National Institutes of Health and by awards from
the Department of Defense, the American Cancer Society, and the
Juvenile Diabetes Foundations (to P. C.). A preliminary account of
this work was presented in part at the Annual Meeting of the Endocrine
Society June 22, 1999, San Diego, CA.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
**
To whom correspondence should be addressed: Professor and Director
of Research and Training, Div. of Endocrinology, Dept. of Pediatrics,
Mattel Children's Hospital at UCLA, 10833 Le Conte Ave., MDCC 22-315, Los Angeles, CA 90095-1752. Tel.: 310-206-5844; Fax: 310-206-5843;
E-mail: hassy@mednet.ucla.edu.
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
P. M. Yamada and K.-W. Lee
Perspectives in mammalian IGFBP-3 biology: local vs. systemic action
Am J Physiol Cell Physiol,
May 1, 2009;
296(5):
C954 - C976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Y. Chan, L. J. Schedlich, S. M. Twigg, and R. C. Baxter
Inhibition of adipocyte differentiation by insulin-like growth factor-binding protein-3
Am J Physiol Endocrinol Metab,
April 1, 2009;
296(4):
E654 - E663.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Miyako, L. J. Cobb, M. Francis, A. Huang, B. Peng, J. E. Pintar, H. Ariga, and P. Cohen
PAPA-1 Is a Nuclear Binding Partner of IGFBP-2 and Modulates Its Growth-Promoting Actions
Mol. Endocrinol.,
February 1, 2009;
23(2):
169 - 175.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Liao, X. Chen, S. Wang, A. F. Parlow, and J. Xu
Steroid Receptor Coactivator 3 Maintains Circulating Insulin-Like Growth Factor I (IGF-I) by Controlling IGF-Binding Protein 3 Expression
Mol. Cell. Biol.,
April 1, 2008;
28(7):
2460 - 2469.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Zappala, C. Elbi, J. Edwards, J. Gorenstein, M. M. Rechler, and N. Bhattacharyya
Induction of Apoptosis in Human Prostate Cancer Cells by Insulin-Like Growth Factor Binding Protein-3 Does Not Require Binding to Retinoid X Receptor-{alpha}
Endocrinology,
April 1, 2008;
149(4):
1802 - 1812.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. R. Dayton and M. E. White
Cellular and molecular regulation of muscle growth and development in meat animals
J Anim Sci,
April 1, 2008;
86(14_suppl):
E217 - E225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Iosef, T. Gkourasas, C. Y. H. Jia, S. S.-C. Li, and V. K. M. Han
A Functional Nuclear Localization Signal in Insulin-Like Growth Factor Binding Protein-6 Mediates Its Nuclear Import
Endocrinology,
March 1, 2008;
149(3):
1214 - 1226.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. R. Santer, B. Moser, G. A. Spoden, P. Jansen-Durr, and W. Zwerschke
Human papillomavirus type 16 E7 oncoprotein inhibits apoptosis mediated by nuclear insulin-like growth factor-binding protein-3 by enhancing its ubiquitin/proteasome-dependent degradation
Carcinogenesis,
December 1, 2007;
28(12):
2511 - 2520.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Schedlich, A. Muthukaruppan, M. K. O'Han, and R. C. Baxter
Insulin-Like Growth Factor Binding Protein-5 Interacts with the Vitamin D Receptor and Modulates the Vitamin D Response in Osteoblasts
Mol. Endocrinol.,
October 1, 2007;
21(10):
2378 - 2390.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-W. Lee, L. J. Cobb, V. Paharkova-Vatchkova, B. Liu, J. Milbrandt, and P. Cohen
Contribution of the orphan nuclear receptor Nur77 to the apoptotic action of IGFBP-3
Carcinogenesis,
August 1, 2007;
28(8):
1653 - 1658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Seenundun and B. Robaire
Time-Dependent Rescue of Gene Expression by Androgens in the Mouse Proximal Caput Epididymidis-1 Cell Line after Androgen Withdrawal
Endocrinology,
January 1, 2007;
148(1):
173 - 188.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Cobb, B. Liu, K.-W. Lee, and P. Cohen
Phosphorylation by DNA-Dependent Protein Kinase Is Critical for Apoptosis Induction by Insulin-Like Growth Factor Binding Protein-3.
Cancer Res.,
November 15, 2006;
66(22):
10878 - 10884.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. H. Muzumdar, X. Ma, S. Fishman, X. Yang, G. Atzmon, P. Vuguin, F. H. Einstein, D. Hwang, P. Cohen, and N. Barzilai
Central and Opposing Effects of IGF-I and IGF-Binding Protein-3 on Systemic Insulin Action.
Diabetes,
October 1, 2006;
55(10):
2788 - 2796.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Peng, P. J. Malloy, J. Wang, and D. Feldman
Growth Inhibitory Concentrations of Androgens Up-Regulate Insulin-Like Growth Factor Binding Protein-3 Expression via an Androgen Response Element in LNCaP Human Prostate Cancer Cells
Endocrinology,
October 1, 2006;
147(10):
4599 - 4607.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Bhattacharyya, K. Pechhold, H. Shahjee, G. Zappala, C. Elbi, B. Raaka, M. Wiench, J. Hong, and M. M. Rechler
Nonsecreted Insulin-like Growth Factor Binding Protein-3 (IGFBP-3) Can Induce Apoptosis in Human Prostate Cancer Cells by IGF-independent Mechanisms without Being Concentrated in the Nucleus
J. Biol. Chem.,
August 25, 2006;
281(34):
24588 - 24601.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Burrows, J. M. P. Holly, N. J. Laurence, E. G. Vernon, J. V. Carter, M. A. Clark, J. McIntosh, C. McCaig, Z. E. Winters, and C. M. Perks
Insulin-Like Growth Factor Binding Protein 3 Has Opposing Actions on Malignant and Nonmalignant Breast Epithelial Cells that Are Each Reversible and Dependent upon Cholesterol-Stabilized Integrin Receptor Complexes
Endocrinology,
July 1, 2006;
147(7):
3484 - 3500.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, P. Yin, L. A. Bach, and C. Duan
Several Acidic Amino Acids in the N-domain of Insulin-like Growth Factor-binding Protein-5 Are Important for Its Transactivation Activity
J. Biol. Chem.,
May 19, 2006;
281(20):
14184 - 14191.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Cohen
Insulin-like growth factor binding protein-3: insulin-like growth factor independence comes of age.
Endocrinology,
May 1, 2006;
147(5):
2109 - 2111.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oufattole, S. W.-J. Lin, B. Liu, D. Mascarenhas, P. Cohen, and B. D. Rodgers
Ribonucleic Acid Polymerase II Binding Subunit 3 (Rpb3), a Potential Nuclear Target of Insulin-Like Growth Factor Binding Protein-3
Endocrinology,
May 1, 2006;
147(5):
2138 - 2146.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Silha, P. C. Sheppard, S. Mishra, Y. Gui, J. Schwartz, J. G. Dodd, and L. J. Murphy
Insulin-Like Growth Factor (IGF) Binding Protein-3 Attenuates Prostate Tumor Growth by IGF-Dependent and IGF-Independent Mechanisms
Endocrinology,
May 1, 2006;
147(5):
2112 - 2121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. R. Santer, N. Bacher, B. Moser, D. Morandell, S. Ressler, S. M. Firth, G. A. Spoden, C. Sergi, R. C. Baxter, P. Jansen-Durr, et al.
Nuclear insulin-like growth factor binding protein-3 induces apoptosis and is targeted to ubiquitin/proteasome-dependent proteolysis.
Cancer Res.,
March 15, 2006;
66(6):
3024 - 3033.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. G. Amaar, B. Tapia, S.-T. Chen, D. J. Baylink, and S. Mohan
Identification and characterization of novel IGFBP5 interacting protein: evidence IGFBP5-IP is a potential regulator of osteoblast cell proliferation
Am J Physiol Cell Physiol,
March 1, 2006;
290(3):
C900 - C906.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. S. Y. Chan, S. M. Twigg, S. M. Firth, and R. C. Baxter
Insulin-Like Growth Factor Binding Protein-3 Leads to Insulin Resistance in Adipocytes
J. Clin. Endocrinol. Metab.,
December 1, 2005;
90(12):
6588 - 6595.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. Freedland, W. J. Aronson, B. Trock, P. Cohen, C. J. Kane, C. L. Amling, J. C. Presti Jr., M. K. Terris, and for the Shared Equal Access Regional Cancer Hospit
Racial Differences in Prognostic Value of Adult Height for Biochemical Progression Following Radical Prostatectomy
Clin. Cancer Res.,
November 1, 2005;
11(21):
7735 - 7742.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Liu, K.-W. Lee, H. Li, L. Ma, G. L. Lin, R. A.S. Chandraratna, and P. Cohen
Combination Therapy of Insulin-Like Growth Factor Binding Protein-3 and Retinoid X Receptor Ligands Synergize on Prostate Cancer Cell Apoptosis In vitro and In vivo
Clin. Cancer Res.,
July 1, 2005;
11(13):
4851 - 4856.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Grimberg, C. M. Coleman, T. F. Burns, B. P. Himelstein, C. J. Koch, P. Cohen, and W. S. El-Deiry
p53-Dependent and p53-Independent Induction of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid Damage and Hypoxia
J. Clin. Endocrinol. Metab.,
June 1, 2005;
90(6):
3568 - 3574.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-W. Lee, L. Ma, X. Yan, B. Liu, X.-k. Zhang, and P. Cohen
Rapid Apoptosis Induction by IGFBP-3 Involves an Insulin-like Growth Factor-independent Nucleomitochondrial Translocation of RXR{alpha}/Nur77
J. Biol. Chem.,
April 29, 2005;
280(17):
16942 - 16948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Silha, Y. Gui, S. Mishra, A. Leckstrom, P. Cohen, and L. J. Murphy
Overexpression of Gly56/Gly80/Gly81-Mutant Insulin-Like Growth Factor-Binding Protein-3 in Transgenic Mice
Endocrinology,
March 1, 2005;
146(3):
1523 - 1531.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. K. Kolluri, M. Corr, S. Y. James, M. Bernasconi, D. Lu, W. Liu, H. B. Cottam, L. M. Leoni, D. A. Carson, and X.-k. Zhang
The R-enantiomer of the nonsteroidal antiinflammatory drug etodolac binds retinoid X receptor and induces tumor-selective apoptosis
PNAS,
February 15, 2005;
102(7):
2525 - 2530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Li, J. Xiang, and C. Duan
Insulin-like Growth Factor-binding Protein-3 Plays an Important Role in Regulating Pharyngeal Skeleton and Inner Ear Formation and Differentiation
J. Biol. Chem.,
February 4, 2005;
280(5):
3613 - 3620.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Zhao, S. Qin, L. I. Atangan, Y. Molina, Y. Okawa, H. T. Arpawong, C. Ghosn, J.-H. Xiao, V. Vuligonda, G. Brown, et al.
Casein Kinase 1{alpha} Interacts with Retinoid X Receptor and Interferes with Agonist-induced Apoptosis
J. Biol. Chem.,
July 16, 2004;
279(29):
30844 - 30849.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Ikezoe, S. Tanosaki, U. Krug, B. Liu, P. Cohen, H. Taguchi, and H. P. Koeffler
Insulin-like growth factor binding protein-3 antagonizes the effects of retinoids in myeloid leukemia cells
Blood,
July 1, 2004;
104(1):
237 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Baege, G. L. Disbrow, and R. Schlegel
IGFBP-3, a Marker of Cellular Senescence, Is Overexpressed in Human Papillomavirus-Immortalized Cervical Cells and Enhances IGF-1-Induced Mitogenesis
J. Virol.,
June 1, 2004;
78(11):
5720 - 5727.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Peng, P. J. Malloy, and D. Feldman
Identification of a Functional Vitamin D Response Element in the Human Insulin-Like Growth Factor Binding Protein-3 Promoter
Mol. Endocrinol.,
May 1, 2004;
18(5):
1109 - 1119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Cobb, D. A. M. Salih, I. Gonzalez, G. Tripathi, E. J. Carter, F. Lovett, C. Holding, and J. M. Pell
Partitioning of IGFBP-5 actions in myogenesis: IGF-independent anti-apoptotic function
J. Cell Sci.,
May 1, 2004;
117(9):
1737 - 1746.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Butt, J. L. Martin, K. A. Dickson, F. McDougall, S. M. Firth, and R. C. Baxter
Insulin-Like Growth Factor Binding Protein-3 Expression Is Associated with Growth Stimulation of T47D Human Breast Cancer Cells: The Role of Altered Epidermal Growth Factor Signaling
J. Clin. Endocrinol. Metab.,
April 1, 2004;
89(4):
1950 - 1956.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Xu, S. Li, Y. Zhao, T. J. Maures, P. Yin, and C. Duan
Evidence That IGF Binding Protein-5 Functions as a Ligand-Independent Transcriptional Regulator in Vascular Smooth Muscle Cells
Circ. Res.,
March 19, 2004;
94(5):
e46 - e54.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-W. Lee, B. Liu, L. Ma, H. Li, P. Bang, H. P. Koeffler, and P. Cohen
Cellular Internalization of Insulin-like Growth Factor Binding Protein-3: DISTINCT ENDOCYTIC PATHWAYS FACILITATE RE-UPTAKE AND NUCLEAR LOCALIZATION
J. Biol. Chem.,
January 2, 2004;
279(1):
469 - 476.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Singh, D. Charkowicz, and D. Mascarenhas
Insulin-like Growth Factor-independent Effects Mediated by a C-terminal Metal-binding Domain of Insulin-like Growth Factor Binding Protein-3
J. Biol. Chem.,
January 2, 2004;
279(1):
477 - 487.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. M. Mikheev, S. A. Mikheeva, B. Liu, P. Cohen, and H. Zarbl
A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation
Carcinogenesis,
January 1, 2004;
25(1):
47 - 59.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. R. Edmondson, S. P. Thumiger, G. A. Werther, and C. J. Wraight
Epidermal Homeostasis: The Role of the Growth Hormone and Insulin-Like Growth Factor Systems
Endocr. Rev.,
December 1, 2003;
24(6):
737 - 764.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ikonen, B. Liu, Y. Hashimoto, L. Ma, K.-W. Lee, T. Niikura, I. Nishimoto, and P. Cohen
Interaction between the Alzheimer's survival peptide humanin and insulin-like growth factor-binding protein 3 regulates cell survival and apoptosis
PNAS,
October 28, 2003;
100(22):
13042 - 13047.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Decensi, U. Veronesi, R. Miceli, H. Johansson, L. Mariani, T. Camerini, M. G. Di Mauro, E. Cavadini, G. De Palo, A. Costa, et al.
Relationships between Plasma Insulin-like Growth Factor-I and Insulin-like Growth Factor Binding Protein-3 and Second Breast Cancer Risk in a Prevention Trial of Fenretinide
Clin. Cancer Res.,
October 15, 2003;
9(13):
4722 - 4729.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. D. Payet, X.-H. Wang, R. C. Baxter, and S. M. Firth
Amino- and Carboxyl-Terminal Fragments of Insulin-Like Growth Factor (IGF) Binding Protein-3 Cooperate to Bind IGFs with High Affinity and Inhibit IGF Receptor Interactions
Endocrinology,
July 1, 2003;
144(7):
2797 - 2806.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Liu, F. Lian, D. E. Smith, R. M. Russell, and X.-D. Wang
Lycopene Supplementation Inhibits Lung Squamous Metaplasia and Induces Apoptosis via Up-Regulating Insulin-like Growth Factor-binding Protein 3 in Cigarette Smoke-exposed Ferrets
Cancer Res.,
June 15, 2003;
63(12):
3138 - 3144.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. H. Ngo, R. J. Barnard, P.-S. Leung, P. Cohen, and W. J. Aronson
Insulin-Like Growth Factor I (IGF-I) and IGF Binding Protein-1 Modulate Prostate Cancer Cell Growth and Apoptosis: Possible Mediators for the Effects of Diet and Exercise on Cancer Cell Survival
Endocrinology,
June 1, 2003;
144(6):
2319 - 2324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Schedlich, T. Nilsen, A. P. John, D. A. Jans, and R. C. Baxter
Phosphorylation of Insulin-Like Growth Factor Binding Protein-3 by Deoxyribonucleic Acid-Dependent Protein Kinase Reduces Ligand Binding and Enhances Nuclear Accumulation
Endocrinology,
May 1, 2003;
144(5):
1984 - 1993.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Franklin, R. J. Ferry Jr., and P. Cohen
Rapid Insulin-Like Growth Factor (IGF)-Independent Effects of IGF Binding Protein-3 on Endothelial Cell Survival
J. Clin. Endocrinol. Metab.,
February 1, 2003;
88(2):
900 - 907.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Martin, S. M. Weenink, and R. C. Baxter
Insulin-like Growth Factor-binding Protein-3 Potentiates Epidermal Growth Factor Action in MCF-10A Mammary Epithelial Cells. INVOLVEMENT OF p44/42 AND p38 MITOGEN-ACTIVATED PROTEIN KINASES
J. Biol. Chem.,
January 24, 2003;
278(5):
2969 - 2976.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Alfaro, B. Fraile, M. V. T. Lobo, M. Royuela, R. Paniagua, and M. I. Arenas
Immunohistochemical Detection of the Retinoid X Receptors {alpha}, {beta}, and {gamma} in Human Prostate
J Androl,
January 1, 2003;
24(1):
113 - 119.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. M. Firth and R. C. Baxter
Cellular Actions of the Insulin-Like Growth Factor Binding Proteins
Endocr. Rev.,
December 1, 2002;
23(6):
824 - 854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Cordain, S. Lindeberg, M. Hurtado, K. Hill, S. B. Eaton, and J. Brand-Miller
Acne Vulgaris: A Disease of Western Civilization
Arch Dermatol,
December 1, 2002;
138(12):
1584 - 1590.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Silha, Y. Gui, and L. J. Murphy
Impaired glucose homeostasis in insulin-like growth factor-binding protein-3-transgenic mice
Am J Physiol Endocrinol Metab,
November 1, 2002;
283(5):
E937 - E945.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Silha and L. J. Murphy
Minireview: Insights from Insulin-Like Growth Factor Binding Protein Transgenic Mice
Endocrinology,
October 1, 2002;
143(10):
3711 - 3714.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. J. Butt, K. A. Fraley, S. M. Firth, and R. C. Baxter
IGF-Binding Protein-3-Induced Growth Inhibition and Apoptosis Do Not Require Cell Surface Binding and Nuclear Translocation in Human Breast Cancer Cells
Endocrinology,
July 1, 2002;
143(7):
2693 - 2699.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H.-Y. Lee, K.-H. Chun, B. Liu, S. A. Wiehle, R. J. Cristiano, W. K. Hong, P. Cohen, and J. M. Kurie
Insulin-like Growth Factor Binding Protein-3 Inhibits the Growth of Non-Small Cell Lung Cancer
Cancer Res.,
June 1, 2002;
62(12):
3530 - 3537.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Spagnoli, M. Torello, S. R. Nagalla, W. A. Horton, P. Pattee, V. Hwa, F. Chiarelli, C. T. Roberts Jr., and R. G. Rosenfeld
Identification of STAT-1 as a Molecular Target of IGFBP-3 in the Process of Chondrogenesis
J. Biol. Chem.,
May 17, 2002;
277(21):
18860 - 18867.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. J. London, J.-M. Yuan, G. S. Travlos, Y.-T. Gao, R. E. Wilson, R. K. Ross, and M. C. Yu
Insulin-Like Growth Factor I, IGF-Binding Protein 3, and Lung Cancer Risk in a Prospective Study of Men in China
J Natl Cancer Inst,
May 15, 2002;
94(10):
749 - 754.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. G. Amaar, G. R. Thompson, T. A. Linkhart, S.-T. Chen, D. J. Baylink, and S. Mohan
Insulin-like Growth Factor-binding Protein 5 (IGFBP-5) Interacts with a Four and a Half LIM Protein 2 (FHL2)
J. Biol. Chem.,
March 29, 2002;
277(14):
12053 - 12060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Hong, G. Zhang, F. Dong, and M. M. Rechler
Insulin-like Growth Factor (IGF)-binding Protein-3 Mutants That Do Not Bind IGF-I or IGF-II Stimulate Apoptosis in Human Prostate Cancer Cells
J. Biol. Chem.,
March 15, 2002;
277(12):
10489 - 10497.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Clemmons
Use of Mutagenesis to Probe IGF-Binding Protein Structure/Function Relationships
Endocr. Rev.,
December 1, 2001;
22(6):
800 - 817.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Walker, E. M. Wilson, D. Powell, and Y. Oh
Butyrate, a Histone Deacetylase Inhibitor, Activates the Human IGF Binding Protein-3 Promoter in Breast Cancer Cells: Molecular Mechanism Involves an Sp1/Sp3 Multiprotein Complex
Endocrinology,
September 1, 2001;
142(9):
3817 - 3827.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R C Baxter
Signalling pathways involved in antiproliferative effects of IGFBP-3: a review
Mol. Pathol.,
June 1, 2001;
54(3):
145 - 148.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. P. Chokkalingam, K. A. McGlynn, Y.-T. Gao, M. Pollak, J. Deng, I. A. Sesterhenn, F. K. Mostofi, J. F. Fraumeni Jr., and A. W. Hsing
Vitamin D Receptor Gene Polymorphisms, Insulin-like Growth Factors, and Prostate Cancer Risk: A Population-based Case-Control Study in China
Cancer Res.,
June 1, 2001;
61(11):
4333 - 4336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. A. BROCKMANN, C. S. HALEY, E. WOLF, S. KARLE, J. KRATZSCH, U. RENNE, M. SCHWERIN, and A. HOEFLICH
Genome-wide search for loci controlling serum IGF binding protein levels of mice
FASEB J,
April 1, 2001;
15(6):
978 - 987.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|